Shogo Kobayashi

45PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|May 07, 2026
Relationship Between Radiographic and Pathological Portal Vein-Superior Mesenteric Vein Involvement in Neoadjuvant Treatment for Pancreatic Cancer: A Comparative Study of Neoadjuvant Chemotherapy and Chemoradiotherapy.

|Jan 06, 2026
Can preoperative spirometry be omitted for HBP surgery?

Takeshi Kado, Yoshito Tomimaru, Shogo Kobayashi

|Nov 17, 2025
Neoadjuvant Chemotherapy With Gemcitabine/Cisplatin/S-1 for Resectable Biliary Tract Cancer With FDG-PET-Positive Lymph Node Metastasis (KHBO1201): A Multicenter Phase II Trial.

Satoshi Ogiso, Etsuro Hatano, Satoru Seo

|Nov 07, 2025
Discrepancy Between Radiographic and Pathological Response Assessment in Neoadjuvant Treatment for Pancreatic Cancer: A Comparison Between Neoadjuvant Chemotherapy and Neoadjuvant Chemoradiotherapy.

Satoru Miyahara, Hidenori Takahashi, Yoshito Tomimaru

|Aug 27, 2025
Tumor Endothelial Cells Induce M2 Macrophage Polarization via IL-4, Enhancing Tumor Growth in Hepatocellular Carcinoma.

Daijiro Matoba, Takehiro Noda, Shogo Kobayashi

|Jul 29, 2025
ASO Visual Abstract: Efficacy of SOAT1 Inhibitors Against Pancreatic Cancer with TP53 Mutations.

Ryosuke Maki, Yoshifumi Iwagami, Shogo Kobayashi

Pageof 8

Frequent Collaborators

13 joint publications

Hidetoshi Eguchi

10 joint publications

Takehiro Noda

10 joint publications

Daisaku Yamada

7 joint publications

Yoshito Tomimaru